(Q37229270)

19 August 2017

1 reference

title

Anticancer drug therapy in the older cancer patient: pharmacology and polypharmacy (English)

1 reference

19 August 2017

1 reference

1 reference

Stuart M Lichtman

1

0 references

author name string

Manpreet K Boparai

series ordinal

2

1 reference

19 August 2017

1 June 2008

1 reference

Current Treatment Options in Oncology

19 August 2017

1 reference

19 August 2017

9

1 reference

19 August 2017

191-203

1 reference

19 August 2017

2-3

1 reference

https://scigraph.springernature.com/pub.10.1007/s11864-008-0060-6

19 August 2017

0 references

cites work

Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11864-008-0060-6

Adherence to therapy with oral antineoplastic agents

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11864-008-0060-6

Medication use leading to emergency department visits for adverse drug events in older adults.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11864-008-0060-6

Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendations.

21 January 2018

1 reference

12 December 2020

Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565.

1 reference

12 December 2020

Age and sex are independent predictors of 5-fluorouracil toxicity. Analysis of a large scale phase III trial

1 reference

12 December 2020

Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials

1 reference

12 December 2020

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

1 reference

12 December 2020

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline

1 reference

12 December 2020

Altered clearance of unbound paclitaxel in elderly patients with metastatic breast cancer

1 reference

12 December 2020

AIDES to improving medication adherence in older adults

1 reference

12 December 2020

Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer.

1 reference

12 December 2020

Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management

1 reference

12 December 2020

Age and adjuvant chemotherapy use after surgery for stage III colon cancer

1 reference

12 December 2020

The pharmacokinetics and pharmacodynamics of fludarabine phosphate in patients with renal impairment: a prospective dose adjustment study

1 reference

12 December 2020

Chemotherapy in the elderly

1 reference

12 December 2020

Updating the Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

1 reference

12 December 2020

A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer.

1 reference

12 December 2020

Pharmacokinetics and toxicity of weekly docetaxel in older patients

1 reference

12 December 2020

High-dose melphalan (200 mg/m2) supported by autologous stem cell transplantation is safe and effective in elderly (>or=65 years) myeloma patients: comparison with younger patients treated on the same protocol

1 reference

12 December 2020

Patient education: the cornerstone of successful oral chemotherapy treatment

1 reference

12 December 2020

Intermediate-dose (25mg/m2) IV melphalan for multiple myeloma with renal failure.

1 reference

12 December 2020

A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients

1 reference

12 December 2020

Dose-escalating and pharmacological study of oxaliplatin in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study

1 reference

12 December 2020

Potentially inappropriate medication use in elderly patients receiving home health care: a retrospective data analysis

1 reference

12 December 2020

Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.

1 reference

12 December 2020

Adherence to Medication

1 reference

12 December 2020

Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients

1 reference

12 December 2020

Capecitabine as adjuvant treatment for stage III colon cancer

1 reference

12 December 2020

Life-threatening myelosuppression in patients with occult renal impairment receiving topotecan

1 reference

12 December 2020

Polypharmacy in the elderly: a literature review

1 reference

12 December 2020

A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863.

1 reference

12 December 2020

Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Bre

1 reference

12 December 2020

Explicit criteria for determining potentially inappropriate medication use by the elderly. An update

1 reference

12 December 2020

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

1 reference

12 December 2020

Elderly Patients Benefit From Second-Line Cytotoxic Chemotherapy: A Subset Analysis of a Randomized Phase III Trial of Pemetrexed Compared With Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

1 reference

12 December 2020

Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly

1 reference

12 December 2020

Phase II clinical trial of chemotherapy-naive patients > or = 70 years of age treated with erlotinib for advanced non-small-cell lung cancer

1 reference

12 December 2020

Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials

1 reference

12 December 2020

Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2.

1 reference

12 December 2020

XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer

1 reference

12 December 2020

Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer

1 reference

12 December 2020

Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors.

1 reference

12 December 2020

Adherence to long-term therapies: evidence for action

1 reference

12 December 2020

Phase I and pharmacokinetic study of pemetrexed administered every 3 weeks to advanced cancer patients with normal and impaired renal function

1 reference

12 December 2020

International Society of Geriatric Oncology (SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal insufficiency

1 reference

12 December 2020

Topotecan dosing guidelines in ovarian cancer: reduction and management of hematologic toxicity

1 reference

12 December 2020

Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer an

1 reference

12 December 2020

Carboplatin dosing formulae: gender bias and the use of creatinine-based methodologies

1 reference

12 December 2020

Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study

1 reference

12 December 2020

Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer

1 reference

12 December 2020

Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762)

1 reference

12 December 2020

Assessing potentially inappropriate prescribing in the elderly Veterans Affairs population using the HEDIS 2006 quality measure.

1 reference

12 December 2020

Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer

1 reference

12 December 2020

Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062).

1 reference

12 December 2020

Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: an oncopaz cooperative group study

1 reference

12 December 2020

Inappropriate prescribing in the elderly: a comparison of the Beers criteria and the improved prescribing in the elderly tool (IPET) in acutely ill elderly hospitalized patients

1 reference

12 December 2020

10.1007/S11864-008-0060-6

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18663583